Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The Mexico Medical Devices Market reached a value of USD 8.41 Billion at 2025 and is projected to expand at a CAGR of around 5.30% during the forecast period of 2026-2035. With nearshoring-led manufacturing expansion, COFEPRIS regulatory streamlining, IMSS-Bienestar hospital build-out, and rising chronic disease burden, the market is expected to reach USD 14.10 Billion.
Base Year
Historical Period
Forecast Period
According to Dongning Su et al., 2025, Mexico is projected to witness a 171% rise in patient numbers from 2021 to 2050, significantly driving demand for advanced medical devices and boosting market growth.
After December 2024, increasing nearshoring of manufacturing in Mexico, supported by supply chain resilience and cost efficiency, is accelerating growth in the medical devices market, making the country a key production hub despite tariff pressures.
One of the major market drivers is the launch of Mexico’s new consolidated procurement model. For instance, in October 2024, the government announced a 130-billion-peso investment to streamline procurement and boost medical device accessibility.
Compound Annual Growth Rate
5.3%
Value in USD Billion
2026-2035
*this image is indicative*
The Mexico medical devices market is being reshaped by four reinforcing forces in 2025–2026: a regulatory overhaul that accepts foreign approvals, a nearshoring-led manufacturing build-out, a multi-billion-dollar IMSS-Bienestar hospital and equipment procurement push, and the embedding of AI and connected technologies into cardiology, imaging and remote-monitoring devices.
Effective September 1, 2025, COFEPRIS launched an Abbreviated Regulatory Pathway recognising approvals from IMDRF and MDSAP authorities such as the U.S. FDA, Health Canada, EMA, Swissmedic and TGA, with a 30-business-day decision target. The reform converts Mexico from a secondary-launch geography into a viable priority market and is already pulling forward registration plans for U.S.-cleared devices in cardiology, imaging and diabetes care.
In February 2026, the Mexican Association of Innovative Medical Device Industries (AMID) projected up to USD 400 million in industry capital deployment between 2026 and 2030, framed within the federal Plan México strategy. The capital is earmarked for manufacturing expansion, R&D, logistics platforms and workforce training, and represents a baseline scenario shaped by USMCA-review uncertainty and supports the Mexico Medical Devices Market growth.
In July 2025, the federal government confirmed plans to inaugurate 31 hospitals and 12 clinics by year-end across IMSS, ISSSTE and IMSS-Bienestar, with about MX$4 billion (~USD 200 million) earmarked for equipment so that no facility lacks fully equipped operating rooms or imaging suites. This multi-year procurement pipeline anchors visible demand for diagnostic imaging, surgical, cardiology and respiratory devices through the late 2020s.
April 2025, GE HealthCare launched the Revolution Vibe CT system featuring Unlimited One-Beat Cardiac imaging and AI-enabled workflow tools, while Philips and Siemens Healthineers expanded their AI cardiac ultrasound and echocardiography portfolios over the same window. Mexican private hospital networks and IMSS modernisation projects are early adopters, leveraging AI tools to compensate for radiologist shortages and to standardise interpretation across distributed sites.
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product
Key Insight: Diagnostic imaging devices anchor the product mix in Mexico, supported by a steady wave of CT, MRI, ultrasound and digital X-ray procurement under IMSS-Bienestar and ISSSTE modernisation, plus premium installations by border medical-tourism hospitals. The Mexico diagnostic imaging equipment market alone was valued at about USD 1.13 billion in 2025 and is projected to reach USD 1.61 billion by 2031 at a 6.05% CAGR, with MRI revenues rising fastest at around 8% CAGR. Cardiology devices are a close second, driven by stent, catheter, ECG and electrophysiology demand. Vendors such as GE HealthCare, Siemens Healthineers, Philips, Medtronic and Abbott are layering AI-enabled imaging and connected-device platforms on top of the installed base, lifting average selling prices.
Market Breakup by Application
Key Insight: Cardiology is the leading application in Mexico and is expected to retain that position through the forecast period, accounting for roughly 28% of medical device revenue. The driver is structural: ischemic heart disease together with diabetes mellitus produced more than 200,000 deaths in 2022, making cardiovascular conditions the single largest mortality cluster in the country. This translates into sustained demand for stents, catheters, pacemakers, defibrillators, ECG and remote cardiac monitoring solutions across IMSS, ISSSTE and private hospital networks. Diabetes care, oncology and orthopedics follow as material categories, all benefiting from rising procedural volumes, an ageing population and growing acceptance of minimally invasive techniques.
Market Breakup by End User
Key Insight: Hospitals are the dominant end user, absorbing the majority of high-value diagnostic, surgical and cardiology equipment sold in Mexico. Public networks (IMSS, ISSSTE and IMSS-Bienestar) are scaling capacity, with 31 hospitals and 12 clinics targeted for inauguration by end-2025 and around 256 operating rooms being upgraded across the three systems. Specialty clinics are growing fastest, particularly in dental, ophthalmology, dermatology and fertility, often clustered in border cities serving medical-tourism inflows. Homecare adoption is climbing on the back of remote patient monitoring, wearables and connected respiratory and diabetes devices, while ambulatory surgical centres are extending procedure mix into orthopedics and minimally invasive cardiology.
Market Breakdown by Region
Key Insight: Northern Mexico is the leading regional cluster, anchored by Tijuana and Mexicali in Baja California, Ciudad Juárez in Chihuahua, and Hermosillo in Sonora. Baja California alone hosts roughly 44 medical device companies, around 42,000 jobs and approximately USD 3 billion in annual exports, while Chihuahua employs about 40,000 people in the sector. The state of Querétaro, in central Mexico, is being elevated by Abbott’s USD 200 million electrophysiology plant inaugurated in early 2026, which is expected to scale toward 1,200 specialised positions by the end of the decade. Guadalajara has emerged as the R&D and electronics-focused medtech hub. Demand drivers include nearshoring under USMCA, federal Plan México incentives, IMSS-Bienestar hospital openings, and an installed base of more than 700 specialised companies and 160,000 sector workers.
By Product: Imaging Devices Lead on Public Healthcare Investments
Diagnostic imaging devices represent the leading product category in Mexico, capturing the largest single share of medical device spending. The pull comes from public-sector modernisation: nine new IMSS hospitals slated for 2025 are being equipped with CT, MRI, ultrasound and digital X-ray suites, and Chiapas alone received around MX$677.5 million (USD 35 million) for imaging upgrades. The forthcoming 260-bed IMSS hospital in Nuevo León (budgeted at about USD 165 million) will feature hybrid operating rooms with interventional imaging. Private medical-tourism hospitals along the border install premium MRI and CT scanners to serve U.S. patients, reinforcing the segment’s dominance. Cardiology devices follow closely, with the cardiology application expected to lead with around a 28% share of total device revenue.
By Application: Cardiology Dominates Amid Rising Disease Burden
Cardiology is the dominant application segment, projected to capture approximately 28% of Mexico’s medical device revenue. The reason is the country’s disease profile: cardiac diseases - 76.3% of which are ischemic heart disease - together with diabetes mellitus accounted for more than 200,000 deaths in 2022 according to peer-reviewed Mexican mortality data. This drives sustained demand for diagnostic ECG, remote cardiac monitoring, stents, catheters, heart valves and electrophysiology devices, supplied by Medtronic, Abbott, Boston Scientific, Edwards Lifesciences, GE HealthCare, Siemens Healthineers and Philips. Abbott’s January 2026 inauguration of a USD 200 million electrophysiology plant in Querétaro is the most visible signal of cardiology’s share leadership and the reason it continues to attract dedicated FDI.
By End User: Hospitals Anchor Demand Through Large-Scale Procurement
Hospitals dominate the end-user mix, mirroring the broader Latin American pattern in which hospitals and ambulatory surgical centres account for roughly 62% of regional device consumption. In Mexico, IMSS, ISSSTE and IMSS-Bienestar collectively control most public-sector procurement, and the 2025-2026 consolidated procurement programme - covering 4.9 billion units across more than 4,400 product codes - runs through hospital networks. The federal government is also upgrading 256 operating rooms across the three systems and has allocated about MX$1.7 billion (USD 100 million) for 123 imaging systems across 26 states. This institutional purchasing power, combined with private hospital expansion and medical-tourism investment, secures hospitals as the principal device demand centre, while specialty clinics expand fastest in absolute growth terms.
Northern Mexico
Northern Mexico is the country’s manufacturing engine for medical devices and the dominant regional sub-market on the supply side. The Baja California cluster, anchored by Tijuana and Mexicali, hosts about 44 medical device companies, 42,000 jobs and around USD 3 billion in annual exports. Becton Dickinson is investing roughly USD 80 million in a third Ciudad Juárez plant scheduled to begin operations in 2026, while Stryker, Medtronic, Johnson & Johnson MedTech and Becton Dickinson all operate multiple plants across Tijuana, Mexicali and Juárez. Demand drivers include USMCA duty-free access to the U.S. market, 24–48-hour border logistics, and labour costs at roughly one-fifth of U.S. levels. Border medical-tourism hospitals further boost local installed-base demand for imaging and orthopedic systems.
Central Mexico
Central Mexico - covering Mexico City, Querétaro, Guanajuato and Jalisco - is the country’s fastest-rising regional sub-market on the demand side and an emerging manufacturing pole. Querétaro has been transformed by Abbott’s USD 200 million electrophysiology plant, inaugurated in January 2026, which currently employs about 300 staff and is scaling to over 1,200 positions; the state has a pipeline of around 57 investment projects totalling close to USD 3.75 billion. Guadalajara, in Jalisco, hosts the high-tech medtech R&D ecosystem (often called the country’s “Silicon Valley”). Mexico City concentrates the largest hospital networks, multinational commercial offices and flagship public institutes such as the Instituto Nacional de Pediatría, where United Imaging deployed Mexico’s first digital pediatric PET/CT in July 2024.
The Mexico medical devices market is moderately consolidated. A small number of multinationals - Medtronic, Johnson & Johnson MedTech, Abbott, GE Healthcare, Siemens Healthineers, Koninklijke Philips, Fresenius Medical Care and 3M - dominate the high-value cardiology, imaging, dialysis and surgical segments, while a long tail of distributors and contract manufacturers supports them across Tijuana, Juárez, Querétaro and Guadalajara.
Competitive priorities have shifted from pure price to operational fit, regulatory speed under the COFEPRIS abbreviated pathway, and AI-enabled product platforms. Strategic moves are focused on near-shore capacity expansion (Abbott Querétaro, BD Juárez), cardiovascular and diabetes franchise reinforcement (Medtronic-Abbott CGM partnership, GE HealthCare Revolution Vibe CT) and selective M&A - including Abbott’s pending USD 21 billion acquisition of Exact Sciences and GE HealthCare’s USD 2.3 billion deal for Intelerad - that reshape the broader competitive set serving Mexico.
Founded in 1949 and headquartered in Dublin, Ireland (operational HQ in Minneapolis, USA), Medtronic plc is the world’s largest medical device company. It focuses on cardiovascular, neuromodulation, surgical and diabetes technologies. In Mexico, Medtronic operates around six manufacturing facilities, including a major plant in Tijuana, with more than 13,000 employees, making it the country’s largest medtech employer and a cornerstone of the cardiology and diabetes device supply chain.
Founded in 1886 and headquartered in New Brunswick, New Jersey (USA), Johnson & Johnson MedTech is the medical devices arm of Johnson & Johnson, with strengths in orthopedics (DePuy Synthes), surgical instruments (Ethicon), cardiovascular and vision care. In Mexico, the company operates manufacturing and commercial activities through Johnson & Johnson de México, S.A. de C.V., supplying hospitals nationwide with surgical, orthopedic and wound-care portfolios.
Founded in 1888 and headquartered in Abbott Park, Illinois (USA), Abbott is a diversified healthcare group with leadership in cardiovascular devices, diabetes care (FreeStyle Libre), neuromodulation and diagnostics. In Mexico, Abbott employs roughly 1,450 people across offices in Mexico City and Querétaro and inaugurated a new USD 200 million electrophysiology manufacturing plant in Querétaro in January 2026, scaling toward 1,200 specialised jobs by decade-end.
GE HealthCare Technologies Inc., spun off from General Electric in January 2023 and headquartered in Chicago, Illinois (USA), is a global leader in diagnostic imaging, ultrasound, patient monitoring and pharmaceutical diagnostics. The company supplies CT, MRI and ultrasound systems to IMSS, ISSSTE and private hospital networks across Mexico, and in November 2025 agreed to acquire imaging-software firm Intelerad for USD 2.3 billion to deepen its cloud-first, AI-enabled imaging stack relevant to Mexican outpatient and ambulatory care.
Other key players in the market are Fresenius Medical Care AG & Co., Koninklijke Philips N.V., Siemens Healthcare GmbH, 3M Company, and Others.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Discover the latest insights on the Mexico Medical Devices Market 2026 with our comprehensive report. Stay ahead of the curve with up-to-date data on product innovation, COFEPRIS regulatory shifts, IMSS-Bienestar procurement waves and the highest-growth regional clusters. Whether you are launching a new device, scaling near-shore manufacturing, or expanding distribution, this report gives you the clarity needed to act with confidence. Download your free sample now and uncover the key opportunities reshaping the thriving Mexico Medical Devices.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
At 2025, the market reached an approximate value of USD 8.41 Billion.
The market is projected to grow at a CAGR of 5.30% between 2026 and 2035.
The market is projected to grow significantly during the forecast period 2026-2035 to reach USD 14.10 Billion by 2035.
Growth is anchored by four reinforcing forces: the rising chronic disease burden - particularly cardiovascular disease and diabetes; nearshoring of medical device manufacturing into Tijuana, Ciudad Juárez and Querétaro under USMCA and Plan México; the COFEPRIS Abbreviated Regulatory Pathway launched in September 2025 that compresses approval timelines to as little as 30 business days; and large-scale IMSS-Bienestar and ISSSTE hospital openings and operating-room upgrades equipped with imaging, surgical and cardiology technologies.
By product, the market is segmented into respiratory devices, cardiology devices, orthopedic devices, diagnostic imaging devices, endoscopy devices, ophthalmology devices and others. Diagnostic imaging devices currently lead the segment in Mexico, supported by sustained CT, MRI, ultrasound and X-ray procurement under public hospital modernisation and private medical-tourism investment, with cardiology devices forming the closely followed second-largest cluster.
The four defining trends are: (i) the COFEPRIS Abbreviated Regulatory Pathway, effective September 2025, which recognises FDA, EMA, Health Canada and other IMDRF/MDSAP approvals; (ii) up to USD 400 million in industry investment between 2026 and 2030 announced by AMID under Plan México; (iii) accelerated IMSS-Bienestar hospital and operating-room build-out, with 31 hospitals and 12 clinics targeted for inauguration by end-2025; and (iv) the embedding of AI and connected-device platforms into cardiac imaging, ultrasound and remote patient monitoring portfolios.
The key players in the market include Medtronic plc, Johnson & Johnson MedTech, Fresenius Medical Care AG & Co., Abbott, GE Healthcare, Koninklijke Philips N.V., Siemens Healthcare GmbH, and 3M Company.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share